Joincare(SH:600380)2016-10-27 16:00Financial Performance - Operating revenue for the first nine months reached CNY 7.37 billion, a 13.99% increase from the same period last year[7]. - Net profit attributable to shareholders decreased by 15.13% to CNY 373.78 million compared to the previous year[7]. - Basic earnings per share fell by 15.01% to CNY 0.2395[7]. - The weighted average return on equity decreased by 1.84 percentage points to 7.72%[7]. - Total operating revenue for Q3 2016 reached ¥2,456,573,964.03, an increase of 7.6% compared to ¥2,283,530,816.07 in Q3 2015[29]. - Net profit for the first nine months of 2016 was ¥777,018,920.07, up 2.4% from ¥758,820,434.95 in the same period last year[29]. - Operating costs for the first nine months increased to ¥6,582,206,876.87, a rise of 15.1% from ¥5,720,305,954.53 in the previous year[29]. - The company reported a gross profit margin of approximately 10.0% for Q3 2016, compared to 10.5% in Q3 2015[29]. - The total comprehensive income for the first nine months was ¥777,623,792.54, compared to ¥752,933,742.74 in the same period last year, indicating a growth of 3.3%[30]. Assets and Liabilities - Total assets increased by 19.12% to CNY 16.43 billion compared to the end of the previous year[7]. - Net assets attributable to shareholders rose by 16.06% to CNY 5.46 billion year-on-year[7]. - Total liabilities increased to CNY 6,965,780,587.28, up from CNY 6,488,460,678.42, representing a growth of approximately 7.36% year-over-year[25]. - Current assets decreased to CNY 2,236,416,584.28 from CNY 2,579,042,939.69, a decline of about 13.27%[26]. - The company's non-current assets totaled RMB 7,919,646,346.33, up from RMB 7,518,582,589.06, reflecting an increase of approximately 5.3%[24]. - The total non-current liabilities decreased to CNY 1,256,621,227.60 from CNY 1,423,038,443.36, a decline of about 11.7%[25]. Cash Flow - Net cash flow from operating activities increased by 54.98% to CNY 1.23 billion year-to-date[7]. - Cash and cash equivalents increased by 73.18% to CNY 3,933,065,441.48 from CNY 2,271,090,578.72 due to funds received from the subsidiary's stock issuance[13]. - Operating cash flow net amount increased by 54.98% to CNY 1,225,436,328.55, driven by higher sales collections[14]. - The net cash flow from financing activities increased to ¥1,116,202,276.28, representing a growth of 298.29% compared to the previous period[15]. - Cash inflow from financing activities was CNY 614,956,476.00, down from CNY 1,257,499,676.00 in the same period last year, leading to a net cash flow from financing activities of negative CNY 173,943,259.27[39]. Shareholder Information - The total number of shareholders reached 131,929 by the end of the reporting period[10]. - The largest shareholder, Shenzhen Baiye Yuan Investment Co., Ltd., holds 46.74% of the shares[10]. Investment and Development - Development expenses grew by 42.19% to CNY 112,224,463.17, mainly due to increased research project expenditures by subsidiaries[13]. - Investment income received surged by 408.01% to CNY 43,211,987.48, resulting from cash received from various investments[14]. - The company has a long-term equity investment valued at RMB 378,702,478.12, an increase from RMB 344,028,861.18 at the beginning of the year, indicating a growth of about 10.1%[24]. Commitments and Governance - The company has commitments from its controlling shareholder to avoid direct or indirect competition with Lizhu Group, ensuring no conflict in business operations[16]. - The controlling shareholder has pledged to notify Lizhu Group of any new business opportunities that may compete with its interests[16]. - The company’s independent directors will review compliance with the commitments at least once a year, ensuring adherence to the agreements[17]. - The company is committed to transparency and accountability in its operations, particularly regarding its commitments to avoid competition with its subsidiaries[17].